pillbase.ru

A-27

SOLUTION · ATRIPLEX POLYCARPA POLLEN 30 [hp_X]/mL, ATRIPLEX LENTIFORMIS POLLEN 30 [hp_X]/mL, ATRIPLEX CANESCENS POLLEN 30 [hp_X]/mL

United StatesActive

Marketing holder: DNA Labs, Inc.

Verified 2026-10-09 · openFDA NDC

Composition
  • ATRIPLEX POLYCARPA POLLEN · 30 [hp_X]/mL
  • ATRIPLEX LENTIFORMIS POLLEN · 30 [hp_X]/mL
  • ATRIPLEX CANESCENS POLLEN · 30 [hp_X]/mL
Registration
Registration number
58264-0319
Registration status
Active
Dispensing
Over the counter
Route
SUBLINGUAL
Sources
  • product · openFDA NDC · 58264-0319 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 58264-0319 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 58264-0319 · Verified 2026-10-09 · open in source
  • ingredients.1 · openFDA NDC · 58264-0319 · Verified 2026-10-09 · open in source
  • ingredients.2 · openFDA NDC · 58264-0319 · Verified 2026-10-09 · open in source